PharmAla Biotech (CSE:MDMA) has been contracted as a supplier of MDMA to a clinical trial at Harvard’s Maclean Hospital.
Vous n'êtes pas connecté
Microbot Medical's (MBOT) LIBERTY Endovascular Robotic System trial expands to Baptist Hospital of Miami, promising advancements in clinical outcomes and endovascular procedures.
PharmAla Biotech (CSE:MDMA) has been contracted as a supplier of MDMA to a clinical trial at Harvard’s Maclean Hospital.
Aga Khan University Hospitals in Karachi, Pakistan and Nairobi, Kenya are private, not-for-profit institutions providing high quality health care. The...
Jude Children’s Research Hospital, USA, demonstrates benefits to using genomics and early treatment response to guide risk classification of...
QGEN expands its digital PCR portfolio with the newly launched QIAcuityDx Digital PCR System. The system will be used for clinical testing in oncology...
Nasdaq extends agreement with Nubank to provide AxiomSL regulatory reporting solution to the later and expands presence in Latin America.
Santa Clara County leaders have approved a $315 million effort to acquire and integrate Regional Medical Center into California’s second largest...
Federal, state, and territory Skills and Training Ministers convened in Melbourne have launched the National Skills Plan, a key initiative of the...
Competitive + Benefits: Astellas Europe: Lead the cross-functional clinical extended team to ensure efficient and compliant clinical trial set-up,...
Bombay High Court grants bail to Gilbert Baptist, linked to a ₹225 crore credit society fraud, citing long pre-trial detention and trial delays.